-
Signature
-
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub
-
Stock symbol
-
IQV
-
Transactions as of
-
Sep 25, 2023
-
Transactions value $
-
$0
-
Form type
-
3
-
Date filed
-
9/29/2023, 05:03 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
holding |
IQV |
Common Stock |
|
|
|
|
|
25.1K |
Sep 25, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
IQV |
Stock Appreciation Right |
|
|
|
|
|
|
Sep 25, 2023 |
Common Stock |
3.2K |
$183.82 |
Direct |
|
holding |
IQV |
Stock Appreciation Right |
|
|
|
|
|
|
Sep 25, 2023 |
Common Stock |
5.46K |
$250.43 |
Direct |
F2 |
holding |
IQV |
Stock Appreciation Right |
|
|
|
|
|
|
Sep 25, 2023 |
Common Stock |
3.43K |
$232.11 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President, Research & Development Solutions.